cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
Bayu Brahma
Contact Email
journal.cancer@gmail.com
Phone
+628176389956
Journal Mail Official
admin@indonesianjournalofcancer.or.id
Editorial Address
National Cancer Center - Dharmais Cancer Hospital Research and Development Building, 3rd-floor Jl. Letjen S. Parman Kav. 84-86, Slipi West Jakarta
Location
Kota adm. jakarta barat,
Dki jakarta
INDONESIA
Indonesian Journal of Cancer
Published by National Cancer Center-Dharmais Cancer Hospital
ISSN : 19783744     EISSN : 23556811     DOI : https://www.doi.org/ 10.33371
Core Subject : Health, Science,
Biochemistry, Genetics & Molecular Biology Immunology & microbiology Medicine & Pharmacology Public Health
Indonesian Journal of Cancer is a peer-reviewed and open-access journal. This journal is published quarterly (in March, June, September, and December) by Dharmais Cancer Hospital - National Cancer Center. Submissions are reviewed under a broad scope of topics relevant to experimental and clinical cancer research. Articles are original research that needs to be disseminated and written in English. All submitted manuscripts will go through the double-blind peer review and editorial review before being granted acceptance for publication. The journal publishes original research articles, case reports, and review articles under the following categories: cancer management, cancer prevention, cancer etiology, epidemiology, molecular oncology, cancer diagnosis and therapy, tumor pathology, surgical oncology, medical oncology, radiation oncology, interventional radiology, as well as early detection.
Arjuna Subject : Kedokteran - Onkologi
Articles 562 Documents
 1   2   3   4   5 
Expression of Ki67 in Precancerous Squamous Cell Skin Lesion of Mice Induced by DMBA Siti Nurkasanah; Aida S D Hoemardani; Evlina Suzanna Sinuraya
Indonesian Journal of Cancer Vol 13, No 2 (2019): June
Publisher : National Cancer Center - Dharmais Cancer Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (1179.783 KB) | DOI: 10.33371/ijoc.v13i2.638

Abstract

Background: Squamous cell carcinoma (SCC) is an invasive skin cancer that is found in the human skin. SCC growth from the precancerous lesion is known as a wart or papilloma. Ki67 is a protein expressed by cells during proliferation. Cells with higher Ki67 expression showed abnormal regulation of apoptosis. 5-FU is an antimetabolite compound that works as a DNA/RNA pyrimidine antagonist molecule that can induce cell apoptosis. The main objective of this research is to evaluate the inhibition proliferation of precancerous squamous cell in skin lesion induced by DMBA/croton oil treated by using 5-FU cream topically compared to 5% imiquimod cream. Methods: This research assesses three different concentrations of 5-FU cream namely 1%, 2%, and 5% topically on 24 wild type mice divided into 6 groups of 4 each including positive control (with carcinogenesis but without treatment), negative control (without treatment ; normal), carcinogenesis with treatment 5-FU cream (1%, 2%, and 5%) or 5% imiquimod cream. The expression of Ki67 was analyzed using immunohistochemistry. Statistical analysis was performed by one-way ANOVA using SPSS version 23. Results: Based on this research, 5-FU cream treatment during 4 weeks (week 10-week 14) showed the decrease of cumulative number of papilloma (p<0.05) and immunohistochemistry analysis resulted in the lowest Ki67 expression in 5-FU 2% and 5% groups compared to 5% imiquimod cream (p<0.05). Conclusions: 5-FU cream treatment during 4 weeks showed a decrease of papilloma and Ki67 expression in 5-FU cream 2% and
Women Living With Breast and Cervical Cancer in the Community: The Face of Surabaya Nowadays Ni Putu Wulan Purnama Sari
Indonesian Journal of Cancer Vol 12, No 4 (2018): October-December
Publisher : National Cancer Center - Dharmais Cancer Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (952.612 KB) | DOI: 10.33371/ijoc.v12i4.605

Abstract

Background: Cervical cancer and breast cancer are the two top leading cases of female cancer in Indonesia. Being the 2nd largest city in Indonesia, Surabaya is being populated by more than 1.5 million females in 2017. This study aimed to describe the demographic characteristic of women living with cervical and breast cancer in order to show the current picture of female cancer situation in Surabayan communities nowadays. Substantial to it, the correlation between time of first diagnosis and type of therapy with current stage of cancer were analyzed to evaluate the cancer management effectiveness in community context.Methods: This cross-sectional study involved six (9.68%) Public Health Centers (PHCs) among 62 PHCs in Surabaya, Indonesia, which were selected by one stage cluster random sampling. There were 140 and 139 women living with cervical and breast cancer participated in this study respectively (n=279). Self-developed demographic questionnaire was used to collect the data. Descriptive statistic, Spearman Rank correlation test, and Mann-Whitney U test were used in data analysis (α<.05).Results: Overall, most respondents were married (77.06%) and were housewives (59.14%). They were high school graduated at majority (44.44%). Family support came from spouse and children (70.25%). Those with breast cancer mostly aged middle-up adulthood (56.12%), while older aged were found in respondents with cervical cancer (72.86%). The majority had been diagnosed with cancer for less than five years (81.36%), but there was a tendency that the longer life expectancy was found in those with cervical cancer. More cervical cancer respondents with advanced stage were found to be long-term survivors (25%). The first time of diagnosis and the type of therapy were significantly different between cases (p=.039 and p=.000 respectively), but the current stage of cancer was not significantly different (p=.239). There was a quite strong correlation between time of first diagnosis and current stage of cancer (ρ = -.409; p=.000), but there was no significant correlation between type of therapy and current stage of cancer (p=.147).Conclusions: The demographic characteristic of women living with cervical and breast cancer has been slowly shifting from elderly or late adulthood, to middle and early adulthood. The first time of diagnosis and the type of therapy were significantly different between cases, but the current stage of cancer was not significantly different. There was a strong significant correlation between time of first diagnosis and current stage of cancer in cervical and breast cancer.
Hubungan Overekspresi HER-2/neu dengan Status Reseptor Hormonal dan Grading Histopatologi pada Penderita Karsinoma Payudara di RS Onkologi Surabaya JACOBUS OCTOVIANUS; SINDRAWATI -; ARIO DJATMIKO
Indonesian Journal of Cancer Vol 6, No 3 (2012): Jul - Sep 2012
Publisher : National Cancer Center - Dharmais Cancer Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v6i3.204

Abstract

Pendahuluan: Overekspresi HER-2/neu merupakan salah satu faktor prognostik dan faktor prediktif yang penting pada karsinoma payudara. Tujuan: menilai hubungan antara overekspresi HER-2/neu dengan faktor yang berkaitan dengan prognosis dan faktor prediksi, yaitu status Reseptor Hormonal dan Grading Histopatologi pada pasien yang datang ke Rumah Sakit Onkologi Surabaya (RSOS). Metode: penelitian retrospektif dengan mencatat data rekam medis penderita karsinoma payudara baru di RS Onkologi Surabaya, sejak Januari 2007 sampai Desember 2010. Data yang dicatat adalah ekspresi HER-2/neu, grading histopatologi, dan status reseptor hormonal.Hasil: di antara 1.426 penderita baru yang datang di RSOS sejak Januari 2007 sampai Desember 2010, terdapat 844 kasus yang dilakukan pemeriksaan histopatologi dan imunohistokimia untuk status reseptor hormonal ER/PR, dan ekspresi HER-2/neu. Overekspresi dari HER-2/neu didapatkan pada 216 penderita (25,6%). Didapatkan prosentase tertinggi kejadian overekspresi HER-2/neu pada rentang usia 55-59 tahun (36,4%), prosentase tertinggi pada status ER (37,1%), PR- (33,7%), dan grading histopatologi yang tinggi (34,6%). Dari hasil analisis statistik didapatkan hubungan yang signifikan antara overekspresi HER-2/neu dengan status ER/PR dan grading histopatologi (p<0,01).Kesimpulan: didapatkan hubungan yang signifikan antara overekspresi HER-2/neu dengan faktor biologi tumor yaitu status ER/PR, grading histopatologi.Kata Kunci: karsinoma payudara, HER-2/neu, usia, reseptor hormonal, grading histopatologi.
Hubungan Peritoneal Carcinomatosis Index dan Predictive Index Value Fagotti dengan Kadar Serum Fatty Acid Binding Protein 4 pada Kanker Ovarium Epitel Stadium Lanjut MUHAMMAD RIZKI YAZNIL; BRAHMANA ASKANDAR TJOKROPRAWIRO; DYAH FAUZIAH
Indonesian Journal of Cancer Vol 11, No 3 (2017): July - September 2017
Publisher : National Cancer Center - Dharmais Cancer Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (873.469 KB) | DOI: 10.33371/ijoc.v11i3.512

Abstract

In advanced ovarian cancer, the main goal of surgery is complete debulking with no visible residual tumor, and predicting it before surgery has become a goal that still unresolved. The ability in advanced ovarian cancer surgery varied between healthcare facilities. Recent discovery put forward the role of fatty acid as one of the main source of energy for ovarian cancer aggresiveness and the role of fatty acid binding protein (FABP) escpecially FABP4 expression as an important biomarker for predicting residual disease in ovarian cancer. There are no data about FABP4 serum in ovarian cancer and it’s role in predicting the extensiveness of advanced stage ovarian cancer. To evaluate correlation between FABP4 serum level with PIV Fagotti Score and Peritoneal Carcinomatosis Index (PCI) in advanced stage ovarian cancer. Analytic observational study. Among 28 subjects, most age groups (46.4%) are 40–45 years of age, 46.4% with normal body mass index, 71.4% with ovarian cancer stage IIIC, 75% with high grade serous adenocarcinoma, average ascites volume 3232.1 ± 2006.9 mL, median CA125 serum 1094 u/mL (12–19425 u/mL). The rate of optimal and complete debulking is 53.5% from 28 subjects. Strong expression of FABP4 on 42.9% subjects. MeanFABP serum 69.6 ± 51.4 ng/mL. Mean PCI score is 14.5 (3–29), mean PIV score is 6 (2–12). There is a significant correlation between FABP4 expression and FABP4 serum level (p<0.05) with moderate power (r=0.55), and a significant correlation with moderate power (r=0.421) between FABP4 serum level with PCI and PIV score. There is a significant correlation with moderate power between rising FABP4 serum and the extent of peritoneal carcinomatosis evaluated by PCI and PIV Fagotti Score in advanced stage ovarian cancer.ABSTRAKPrediksi resektabilitas pada kanker ovarium epitel masih merupakan masalah penting yang belum terpecahkan. Penelitian-penelitian mutakhir mengemukakan peran dari asam lemak sebagai salah satu sumber energi penting bagi progresivitas kanker ovarium. FABP4 sebagai salah satu protein yang berperan dalam transportasi asam lemak merupakan salah satu biomarker yang dijumpai pada kanker ovarium dengan residu tumor. Akan tetapi, penelitian mengenai kadar serum FABP4 pada stadium lanjut belum ada. Selain itu, apakah PCI dan PIV skor Fagotti mempunyai hubungan dengan kadar serum FABP4 pada kanker ovarium stadium lanjut belum pernah diteliti. Penelitian ini bertujuan untuk menilai korelasi antara PIV skor Fagotti dan PCI dengan kadar serum FABP4 pada penderita kanker ovarium stadium lanjut. Observasional analitik digunakan dalam penelitian ini, di mana peneliti ingin melihat korelasi antara nilai skor PIV skor Fagotti dan PCI dengan kadar serum FABP4. Subjek penelitian berjumlah 28 orang dengan karakteristik: kelompok usia terbanyak 40–45 tahun (46,4%); indeks massa tubuh normal (46,4%); stadium FIGO IIIC (71,4%); high grade serous ovarian cancer (75%); jumlah rerata asites 3232,1 ± 2006,9 mL; median kadar serum CA125 1094 u/mL (12–19425 u/mL); 53,5% subjek dapat dilakukan sitoreduksi optimal dan komplit. Ekspresi FABP4 yang kuat terjadi pada 42,9% subjek. Rerata kadar serum FABP4 69,6 ± 51,4 ng/mL. Korelasi signifikan antara ekspresi FABP4 dengan kadar serum FABP4 pada penelitian ini (p<0,05), dengan tingkat korelasi sedang (r=0,55). Rerata PCI total 14,5. Rerata PIV adalah 6 dengan nilai minimum 2 dan maksimum 12.Didapatkan korelasi signifikan (p<0,05) antara kadar serum FABP4 dengan penilaian PCI dan PIV dengan tingkat korelasi sedang (r=0,421, r=0,458). Pada penelitian ini ditemukan korelasi signifikan dengan kekuatan korelasi sedang antara peningkatan skor PIC dan PIV skor Fagotti dengan peningkatan kadar serum FABP4 pada pasien kanker ovarium stadium lanjut.
Multiple Myeloma in Indonesia Hilman Tadjoedin; Arry Harryanto Reksodiputro; Toman Toruan
Indonesian Journal of Cancer Vol 5, No 2 (2011): Apr - Jun 2011
Publisher : National Cancer Center - Dharmais Cancer Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (75.156 KB) | DOI: 10.33371/ijoc.v5i2.134

Abstract

Tujuan: Melihat karakteristik klinis pasien mieloma multipel di Indonesia.Metode: studi deskriptif, potong lintang, multisenter, dilakukan pada November 2008 sampai dengan November 2009. Tujuh puluh data pasien mieloma multipel diambil dari seluruh Indonesia, dari kelompok studi mieloma multipel di Indonesia.Hasil: Lebih dari enam puluh persen pasien mieloma multipel di Indonesia berusia lebih dari 50 tahun (65,71%) dengan perbadingan jenis kelamin yang kurang lebih sama antara pria dan wanita. Kurang lebih lima puluh persen pasien bersuku Jawa, dengan tingkat pendidikan Sekolah Menengah Atas (SMA) dan tidak bekerja.Lima puluh tiga persen pasien memiliki kurang dari 30% sel plasma di sumsum tulangnya dengan 70% pasien tidak memiliki proteinuria Bence Jones dan 80% pasien memiliki serummonoclonal gammopathyyang positif. Persentase sel plasma di sumsum tulang lebih banyak ditemukan pada pasien yang berusia lebih muda (34,05% vs. 24,24% vs. 7,5%). Dilaporkan bahwa hampir lima puluh persen pasien memiliki stadium IIIA berdasarkan klasifikasiDurie Salmon Staging system. Stadium penyakit yang lebih tinggi berkaitan dengan usia yang lebih tua berdasarkan klasifikasiInternational Myeloma Working Group. Melphalan/prednisone merupakan pilihan kemoterapi yang paling banyak digunakan (59,7%) dengan hasil pengobatan terbanyak adalah respons parsial.Kesimpulan: karakteristik pasien mieloma multipel di Indonesia didominasi oleh suku Jawa, dengan tingkat pendidikan SMA dan tidak bekerja. Sebagian besar pasien memiliki sel plasma kurang dari 30% di sumsum tulang, proteinuria Bence Jones yang negatif, dan serummonoclonal gammopathyyang positif. Hampir lima puluh persen pasien memiliki stadium IIIA dengan melphalan/prednison sebagai jenis kemoterapi terbanyak yang diberikan dengan hasil terbaik sebagian besar adalah respon parsial.Kata kunci: mieloma multipel, karakteristik klinis, Indonesia
Optimalisasi Penatalaksanaan Kanker Buli-Buli Superfisial RAINY UMBAS
Indonesian Journal of Cancer Vol 4, No 1 (2010): Jan - Mar 2010
Publisher : National Cancer Center - Dharmais Cancer Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v4i1.76

Abstract

Diagnosis dini dengan optimalisasi penggunaan pemeriksaan sitologi urin, penanda biologi molekuler, dan sistoskopi merupakan langkah penting dalam penanganan kanker buli-buli superfisial. Penentuan derajat dan stadium tumor sebaiknya dilakukan dengan bekerjasama antar-spesialis terkait mengingat hal ini diperlukan untuk menentukan risiko rekurensi dan progresi penyakit. Optimalisasi cara pengobatan antara lain berupa pemberian instilasi kemoterapi intravesika segera pasca-TUR, persiapan penderita, jumlah dan dosis terapi induksi, serta lama pemberian terapi pemeliharaan akan meningkatkan keberhasilan pengobatan. Mengingat kecenderungan rekurensi dan progresi maka jadwal tindak lanjut berupa sistoskopi harus dilakukan secara ketat sesuai dengan tingkat risiko terhadap kedua hal tersebut.Kata kunci: Sistoskopi, instilasi intravesika, kemoterapi, imunoterapi BCG.
Advance Malignant Phyllodes Tumor with Active Bleeding in Children: A Rare Case Dedy Hermansyah; Fernando Silalahi; Albiner Simarmata; Denny Rifsal Siregar
Indonesian Journal of Cancer Vol 15, No 4 (2021): December
Publisher : National Cancer Center - Dharmais Cancer Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (604.906 KB) | DOI: 10.33371/ijoc.v15i4.797

Abstract

Introduction: Phyllodes tumors are fibroepithelial breast lesions that are uncommon in women and rare among children. Due to scarcity, there are only a few large pediatric phyllodes tumor series. Current guidelines do not differentiate treatment recommendations between children and adults.Case Presentation: A 12-year-old girl presented with a lump in her right breast which grew rapidly within a month. On physical examination, we found a mass on the right breast sized ± 10 x 10 cm; the lump was fragile and bled easily. The patient’s condition was getting worse and worse. Due to this deterioration, we performed a mastectomy immediately.Conclusions: The incidence of malignant phyllodes tumor in children is very rare and required prompt treatment in emergency cases.
Stereotactic Radiosurgery pada Benign Skull Base Tumor HENRY KODRAT; RIMA NOVIRIANTHY
Indonesian Journal of Cancer Vol 10, No 1 (2016): Jan - Mar 2016
Publisher : National Cancer Center - Dharmais Cancer Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (337.829 KB) | DOI: 10.33371/ijoc.v10i1.412

Abstract

ABSTRACTTotal removal is difficult to be performed in skull base tumors because its location is surrounded by important structures such as nerves and blood vessels. Therefore, radiotherapy is one of treatment modalities that has been proven efficacy. Simultaneous with the development of imaging technology and advancement of radiobiology, radiosurgery is an emerging therapeutic modality. Radiosurgery is radiotherapy method which delivers high doseirradiation in single fraction. Rational use of stereotactic radiosurgery on benign skull base tumor is from radiobiology point of view; there is no advantage can be achieved from conventional dose fractionated radiotherapy compared with high dose. However, if we want to delivered high dose radiation, we must apply rigid immobilization, target definition using stereotactic navigation and image guidance verification. Radiosurgery can only be delivered in small intracranial lesion.ABSTRAKReseksi total kadang sulit dilakukan pada tumor yang terletak pada dasar tengkorak. Hal ini disebabkan lokasinya dikelilingi oleh struktur saraf dan pembuluh darah penting. Oleh karena itu, radioterapi merupakan salah satu modalitas terapi yang sudah terbukti maanfaatnya. Sejalan dengan perkembangan teknologi pencitraan dan kemajuan pengetahuan radiobiologi, radiosurgery merupakan modalitas terapi yang melejit penggunannya. Radiosurgery adalah metode pemberian radioterapi dengan dosis tinggi dan diberikan dalam fraksi tunggal. Rasional penggunaan stereotactic radiosurgery pada tumor jinak dasar tengkorak adalah karena dari sudut pandang radiobiologi, tidak ada kelebihan dariradioterapi dengan dosis konvensional dibandingkan dengan dosis tinggi. Namun, untuk pemberian dosis tinggi diwajibkan imobilisasi yang rigid dan lokalisasi yang akurat dengan menggunakan navigasi stereotaktik dan verifikasi dengan panduan pencitraan radiologi. Radiosurgery hanya dapat diberikan pada kelainan intrakranial yang berukuran kecil.
Efektivitas Jus Tomat dan Minuman Bekatul terhadap Pengecilan Ukuran Lesi Kista Payudara Evy Damayanthi; Lilik Kustiyah; Kardinah -
Indonesian Journal of Cancer Vol 5, No 1 (2011): Jan - Mar 2011
Publisher : National Cancer Center - Dharmais Cancer Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (124.558 KB) | DOI: 10.33371/ijoc.v5i1.99

Abstract

Lesi kista payudara tidak hanya memberikan rasa tidak nyaman, tetapi kista jenis tertentu dapat meningkatkan risiko kanker payudara. Mengonsumsi makanan/minuman yang mengandung antioksidan, seperti likopen di tomat dan oryzanol serta tokoferol di bekatul padi, dianjurkan untuk mencegah kanker. Tujuan penelitian adalah mempelajari pengaruh intervensi jus tomat dan minuman bekatul terhadap kista payudara. Rancangan penelitian adalah studi eksperimental. Penelitian dilakukan di Rumah Sakit Dharmais pada Juni 2009 sampai dengan April 2010. Subjek penelitian terdiri dari 2 kelompok, yaitu 10 wanita non-kista dan 10 wanita kista. Selama dua minggu, setiap harinya subyek mengonsumsi 480 ml/hari jus tomat dan dua minggu berikutnya mengonsumsi minuman bekatul (30 g/hari). Hasil penelitian menunjukkan kadar likopen plasma meningkat secara nyata pada kelompok non-kista maupun kista setelah mengonsumsi jus tomat, sedangkan kadar ?-tokoferol plasma setelah mengonsumsi minuman bekatul menurun secara nyata pada kelompok kista, tetapi tidak nyata pada kelompok non-kista. Aktivitas antioksidan total plasma dengan uji DPPH tidak mengalami perubahan yang nyata, baik setelah mengonsumsi jus tomat maupun minuman bekatul. Ukuran lesi kista payudara kanan dan kiri tidak berbeda nyata antara sebelum dan setelah intervensi jus tomat. Setelah intervensi minuman bekatul ukuran lesi kista payudara kiri tidak berbeda nyata dengan sebelum intervensi, tetapi pada payudara kanan, ukuran lesi kista mengecil secara nyata (p<0,05), yaitu dari 11,4+6,2 mm menjadi 8,06+5,37 mm. Hasil penelitian menunjukkan minuman tinggi antioksidan jus tomat dan minuman bekatul kelihatannya memberikan manfaat terhadap pengecilan ukuran lesi kista payudara.Kata kunci: kista payudara, ?-tokoferol, bekatul, likopen, jus tomat, aktivitas antioksidan
Deteksi Dini Gastrointestinal Stromal Tumor Dukut Respati Kastomo
Indonesian Journal of Cancer Vol 2, No 2 (2008): Apr - Jun 2008
Publisher : National Cancer Center - Dharmais Cancer Hospital

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (1166.141 KB) | DOI: 10.33371/ijoc.v2i2.44

Abstract

Gastro Intestinal Stromal Tumor (GIST) merupakan keganasan yang berasal dari jaringan mesenkhim dan dapat ditemukan diseluruh jaringan mesenkhim. Istilah gastrointestinal dipakai karena keganasan ini mula-mula aan terbanyak (dua pertiga tumor stromal) ditemukan ai gaster. Jaringan mesenkhim terletak di submukosa, sehingga dalam keadaan dini liampir tidak mungkin dapat diketahui sampai menimbulkan gejala klinis dari yang ringan sampai berat.Dilakukan reevaluasi hasil pemeriksaan histopatologi kasus dengan diagnosis leiomiosarkoma, leiomioma saluran cerna hasilnya yang ditemukan 22 kasus tumor Gastro Intestinal Strotnal Tumor dari 932 kasus keganasan saluran cerna dari tahun 1995 - 2007.Di RS. Kanker "Dharmais", dari 22 kasus tumor GIST, 8 kasus ditemukan pasca bedah pada pemeriksaan histopatologi dan kedua secara immunohistokimia setelah pada pemeriksaan pertama didiagnosis leiomioma atau leiomiosarkoma. Empat belas kasus lainnya ditemukan secara immunohistokimia pada sediaan penderita yang sudah meninggal. Lokasi terbanyak adalah di lambung (7 kasus), omentum (6 kasus), rektum (3 kasus), esofagus dan jejunum (masing-masing 2 kasus), dan mesokolon dan hati (masing-masing 1 kasus).Kelainan awal pada tumor GIST dapat menimbulkan gangguan ringan gerakan usus, seperti rasa tidak nyaman, mual, sampai mulas. Bila ditemukan gejala obstruksi, kolik, dan perdarahan hal ini biasanya merupakan gejala yang sudah lanjut.Kata kunci: deteksi dini, Gastro Intestinal Stromal Tumor, gangguan peristaltik

Page 3 of 57 | Total Record : 562

 1   2   3   4   5 

Filter by Year

2007 2025


Reset
Filter By Issues
All Issue Vol 19, No 3 (2025): September Vol 19, No 2 (2025): June Vol 19, No 1 (2025): March Vol 18, No 4 (2024): December Vol 18, No 3 (2024): September Vol 18, No 2 (2024): June Vol 18, No 1 (2024): March Vol 17, No 4 (2023): December Vol 17, No 3 (2023): September Vol 17, No 2 (2023): June Vol 17, No 1 (2023): March Vol 16, No 4 (2022): December Vol 16, No 3 (2022): September Vol 16, No 2 (2022): June Vol 16, No 1 (2022): March Vol 15, No 4 (2021): December Vol 15, No 3 (2021): September Vol 15, No 2 (2021): June Vol 15, No 1 (2021): March Vol 14, No 4 (2020): December Vol 14, No 3 (2020): September Vol 14, No 2 (2020): June Vol 14, No 1 (2020): March Vol 13, No 4 (2019): December Vol 13, No 3 (2019): September Vol 13, No 2 (2019): June Vol 13, No 1 (2019): March Vol 12, No 4 (2018): October-December Vol 12, No 3 (2018): July-September Vol 12, No 2 (2018): April-June Vol 12, No 1 (2018): Jan - Mar Vol 11, No 4 (2017): October- December 2017 Vol 11, No 3 (2017): July - September 2017 Vol 11, No 2 (2017): April - June Vol 11, No 1 (2017): Jan-Mar Vol 10, No 4 (2016): October - December 2016 Vol 10, No 3 (2016): July - September 2016 Vol 10, No 2 (2016): April - June 2016 Vol 10, No 1 (2016): Jan - Mar 2016 Vol 9, No 4 (2015): Okt - Des 2015 Vol 9, No 3 (2015): Jul - Sept 2015 Vol 9, No 2 (2015): April-Juni 2015 Vol 9, No 1 (2015): Jan - Mar 2015 Vol 8, No 4 (2014): Oct - Dec 2014 Vol 8, No 3 (2014): Jul - Sep 2014 Vol 8, No 2 (2014): April-Juni 2014 Vol 8, No 1 (2014): Jan - Mar 2014 Vol 7, No 4 (2013): Oct - Dec 2013 Vol 7, No 3 (2013): Jul - Sep 2013 Vol 7, No 2 (2013): Apr - Jun 2013 Vol 7, No 1 (2013): Jan - Mar 2013 Vol 6, No 4 (2012): Oct - Dec 2012 Vol 6, No 3 (2012): Jul - Sep 2012 Vol 6, No 2 (2012): Apr - Jun 2012 Vol 6, No 1 (2012): Jan - Mar 2012 Vol 5, No 4 (2011): Oct - Dec 2011 Vol 5, No 3 (2011): Jul - Sep 2011 Vol 5, No 2 (2011): Apr - Jun 2011 Vol 5, No 1 (2011): Jan - Mar 2011 Vol 4, No 4 (2010): Oct - Dec 2010 Vol 4, No 3 (2010): Jul - Sep 2010 Vol 4, No 2 (2010): Apr - Jun 2010 Vol 4, No 1 (2010): Jan - Mar 2010 Vol 3, No 4 (2009): Oct - Dec 2009 Vol 3, No 3 (2009): Jul - Sep 2009 Vol 3, No 2 (2009): Apr - Jun 2009 Vol 3, No 1 (2009): Jan - Mar 2009 Vol 2, No 4 (2008): Oct - Dec 2008 Vol 2, No 3 (2008): Jul - Sep 2008 Vol 2, No 2 (2008): Apr - Jun 2008 Vol 2, No 1 (2008): Jan - Mar 2008 Vol 1, No 4 (2007): Oct - Dec 2007 Vol 1, No 3 (2007): Jul - Sep 2007 Vol 1, No 2 (2007): Apr - Jun 2007 Vol 1, No 1 (2007): Jan - Mar 2007 More Issue